NIH-funded research R21 grant

Understanding how gut bacteria protect against Shigella infection

Official title: Defining human gut microbiome-mediated protection against Shigella infection

Funded at University of California Berkeley · NIH-11094037 · Data updated 2026-11-12

This study is looking at how the bacteria in our gut might help protect us from getting sick with Shigella, which causes diarrhea, by examining stool samples from people before they are exposed to the infection and testing it in mice to see how these helpful bacteria work.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California Berkeley
NIH-funded
Lab location1 site (Berkeley, United States)
Project startMay 23, 2024
Project endMarch 31, 2026
Funding year2025
Award (this year)$200,625
NIH project number5R21AI185665-02
Project IDNIH-11094037 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with diverse gut microbiomes, particularly those who have been exposed to Shigella or are at risk of infection.

Less likely to help

Patients who have a compromised gut microbiome or those who are already infected with Shigella may not benefit from this research.

What this research studies

This research investigates the role of the human gut microbiome in providing protection against Shigella infection, a major cause of diarrheal disease. By analyzing stool samples from individuals before they are exposed to Shigella, researchers aim to identify specific gut bacteria that may confer resistance to the infection. The study will utilize a novel mouse model to further explore how these bacteria interact with Shigella and inhibit its growth. Through advanced sequencing techniques and bacterial culture experiments, the research seeks to uncover the mechanisms behind microbiome-mediated protection.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing Shigella infections, particularly in vulnerable populations such as children.

How similar studies have gone: Previous research has shown promise in understanding the protective roles of gut microbiomes against various infections, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of California Berkeley
    Berkeley, United States
    Active

Researchers

  • Principal investigator: Wolf, Ashley Robin — University of California Berkeley
  • Study coordinator: Wolf, Ashley Robin

Related research

Other NIH-funded projects on the same topics.

  • Multi-agent AI to annotate enzymes in the human gut microbiome

    A team at a major university will build an AI system that automatically curates and labels the functions of enzymes in the human gut microbiome to speed up understanding their health effects.

    NIH research University of South Florida · Tampa, United States · NIH-11594384

  • Mapping how gut bacteria transform drugs

    Scientists will study how the gut microbiome changes thousands of drugs into new forms, which could affect how well a medicine works or whether it causes side effects.

    NIH research Stanford University · Stanford, United States · NIH-11550022

  • Aflatoxin exposure and child growth in Guatemala

    A study in rural Guatemala will track how exposure to aflatoxin relates to growth and gut health in young children.

    NIH research Arizona State University-Tempe Campus · Scottsdale, United States · NIH-11513260

  • Gut bacteria that can make cancer immunotherapy less effective

    This project will see if reducing chronic inflammation driven by certain gut bacteria can help immunotherapy work better for people whose cancers have stopped responding.

    NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11478145

  • How gut bacteria affect how cancer drugs work

    This project looks at how the bacteria in your gut might change how well and with what side effects fluoropyrimidine cancer drugs like 5-FU work in people.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473234

  • Gut bacteria and cancer drugs: how your gut may change chemotherapy effectiveness

    This project studies how the gut microbiome might affect how well certain chemotherapy drugs work and their side effects in people with cancer.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473233

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.